blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1383544

EP1383544 - ANTI-CD19 IMMUNOTOXINS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.02.2009
Database last updated on 30.10.2024
Most recent event   Tooltip20.02.2009Application deemed to be withdrawnpublished on 25.03.2009  [2009/13]
Applicant(s)For all designated states
PROGENICS PHARMACEUTICALS, INC.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2004/05]
Inventor(s)01 / OLSON, William, C.
21 Fawn Court
Ossining, NY 10562 / US
02 / MADDON, Paul, J.
191 Fox Meadow Road
Scarsdale, NY 10583 / US
03 / MA, Dangshe
49 Glenwood Road
Millwood, NY 10546 / US
 [2004/05]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2004/05]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date02728621.029.03.2002
[2004/05]
WO2002US09889
Priority number, dateUS20010282587P09.04.2001         Original published format: US 282587 P
[2004/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02080987
Date:17.10.2002
Language:EN
[2002/42]
Type: A1 Application with search report 
No.:EP1383544
Date:28.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2002 takes the place of the publication of the European patent application.
[2004/05]
Search report(s)International search report - published on:US17.10.2002
(Supplementary) European search report - dispatched on:EP12.11.2007
ClassificationIPC:A61K51/10, A61K39/395, C07K16/46
[2004/05]
CPC:
A61K51/1027 (EP,US); A61K51/1096 (EP,US); A61P19/02 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P7/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/05]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANTI-CD19-IMMUNOTOXINE[2004/05]
English:ANTI-CD19 IMMUNOTOXINS[2004/05]
French:IMMUNOTOXINES ANTI-CD19[2004/05]
Entry into regional phase27.10.2003National basic fee paid 
27.10.2003Search fee paid 
27.10.2003Designation fee(s) paid 
27.10.2003Examination fee paid 
Examination procedure02.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
27.10.2003Amendment by applicant (claims and/or description)
27.10.2003Examination requested  [2004/05]
16.05.2008Despatch of a communication from the examining division (Time limit: M04)
30.09.2008Application deemed to be withdrawn, date of legal effect  [2009/13]
04.11.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/13]
Fees paidRenewal fee
26.04.2004Renewal fee patent year 03
22.03.2005Renewal fee patent year 04
29.03.2006Renewal fee patent year 05
28.03.2007Renewal fee patent year 06
27.03.2008Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.03.200403   M06   Fee paid on   26.04.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - UCKUN F M ET AL, "IN-VIVO EFFICACY OF B43 ANTI-CD19-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN AGAINST BCL-1 MURINE B-CELL LEUKEMIA", BLOOD, (1992), vol. 79, no. 10, ISSN 0006-4971, pages 2649 - 2661, XP002456362 [X] 1-42 * the whole document *
 [X]  - STONE MARVIN J ET AL, "A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma", BLOOD, (1996), vol. 88, no. 4, ISSN 0006-4971, pages 1188 - 1197, XP002456363 [X] 1-42 * the whole document *
 [X]  - UCKUN F M ET AL, "IN VIVO EFFICACY OF B43 (ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN AGAINST HUMAN PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, (19920501), vol. 79, no. 9, ISSN 0006-4971, pages 2201 - 2214, XP000611286 [X] 1-42 * the whole document *
 [Y]  - VAN OOSTERHOUT YPKE V J M ET AL, "Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins", CANCER RESEARCH, (1994), vol. 54, no. 13, ISSN 0008-5472, pages 3527 - 3532, XP002456364 [Y] 1-42 * the whole document *
 [Y]  - FUNARO A ET AL, "Monoclonal antibodies and therapy of human cancers", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, (200008), vol. 18, no. 5, ISSN 0734-9750, pages 385 - 401, XP004211816 [Y] 1-42 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0734-9750(00)00043-4
 [T]  - NELSON E L ET AL, "TUMOR-SPECIFIC, CYTOTOXIC T-LYMPHOCYTE RESPONSE AFTER IDIOTYPE VACCINATION FOR B-CELL, NON-HODGKIN'S LYMPHOMA", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, (1996), vol. 88, no. 2, ISSN 0006-4971, pages 580 - 589, XP000891259 [T] 1-42 * the whole document *
 [T]  - VOENA C ET AL, "A NOVEL NESTED-PCR STRATEGY FOR THE DETECTION OF REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN GENES IN B CELL TUMORS", LEUKEMIA, MACMILLAN PRESS LTD, US, (1997), vol. 11, no. 10, ISSN 0887-6924, pages 1793 - 1798, XP000891278 [T] 1-42 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.leu.2400801
International search[Y]US5686072  (UHR JONATHAN W [US], et al);
 [Y]US6146628  (UCKUN FATIH M [US], et al);
 [Y]US5872223  (UCKUN FATIH M [US]);
 [Y]US6160010  (UCKUN FATIH M [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.